Industries de la santé
22 Août 2011
Pluristem and United Therapeutics Announce Closing of the Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension |HAIFA, ISRAEL, August 3, 2011 -- Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR) today announced that following the consent of the Office of the Chief Scientist of Israel, Pluristem's exclusive out-license...